Integrative genome and transcriptome analyses reveal two distinct types of ring chromosome in soft tissue sarcomas

Human Molecular Genetics

Volumn 23, Issue 4, 2014, Pages 878-888

  Nord, Karolin H ^a   Macchia, Gemma ^b   Tayebwa, Johnbosco ^a   Nilsson, Jenny ^a   Von Steyern, Fredrik Vult ^a   Brosjö, Otte ^c   Mandahl, Nils ^a   Mertens, Fredrik ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF BARI   (Italy)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2A; NF1 PROTEIN; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN; PROTEIN MDM2; PROTEIN P53; RB1 PROTEIN; TRANSCRIPTOME; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CHROMOSOMAL INSTABILITY; CHROMOSOME 10P; CHROMOSOME 11Q; CHROMOSOME 12P; CHROMOSOME 12Q; CHROMOSOME 13Q; CHROMOSOME 16Q; CHROMOSOME 17P; CHROMOSOME 17Q; CHROMOSOME 18P; CHROMOSOME 18Q; CHROMOSOME 19Q; CHROMOSOME 1P; CHROMOSOME 1Q; CHROMOSOME 3P; CHROMOSOME 4Q; CHROMOSOME 5P; CHROMOSOME 6Q; CHROMOSOME 7P; CHROMOSOME 7Q; CHROMOSOME 8P; CHROMOSOME 8Q; CHROMOSOME 9P; CHROMOSOME ARM; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; GENE DELETION; GENE DOSAGE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENOME; GENOME ANALYSIS; HUMAN; HUMAN TISSUE; MALE; MARKER CHROMOSOME; MIDDLE AGED; PRIORITY JOURNAL; RING CHROMOSOME; RNA ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; SOFT TISSUE SARCOMA; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CYCLIN-DEPENDENT KINASE 4; FEMALE; GENE AMPLIFICATION; GENE EXPRESSION PROFILING; GENETIC ASSOCIATION STUDIES; GENOME, HUMAN; HMGA2 PROTEIN; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTO-ONCOGENE PROTEINS C-MDM2; RETINOBLASTOMA PROTEIN; RING CHROMOSOMES; SARCOMA; SOFT TISSUE NEOPLASMS; TRANSCRIPTOME;

EID: 84892960740     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddt479     Document Type: Article

References (42)

1. Schwab, M. (1999) Oncogene amplification in solid tumors. Semin. Cancer Biol., 9, 319-325.
2. Albertson, D.G. (2006) Gene amplification in cancer. Trends Genet., 22, 447-455.
3. Knuutila, S., Björkqvist, A.M., Autio, K., Tarkkanen, M., Wolf, M., Monni, O., Szymanska, J., Larramendy, M.L., Tapper, J., Pere, H. et al. (1998)DNA copy number amplifications in human neoplasms: review of comparative genomic hybridization studies. Am. J. Pathol., 152, 1107-1123.
4. Myllykangas, S., Tikka, J., Böhling, T., Knuutila, S. and Hollmén, J. (2008) Classification of human cancers based on DNA copy number amplification modeling. BMC Med. Genomics, 1, 15.
5. Storlazzi, C.T., Lonoce, A., Guastadisegni, M.C., Trombetta, D., D'Addabbo, P., Daniele, G., L'Abbate, A., Macchia, G., Surace, C., Kok, K. et al. (2010) Gene amplification as double minutes or homogeneously staining regions in solid tumors: origin and structure. Genome Res., 20, 1198-1206.
6. Carroll, S.M., DeRose, M.L., Gaudray, P., Moore, C.M., Needham-Vandevanter, D.R., Von Hoff, D.D. and Wahl, G.M. (1988) Double minute chromosomes can be produced from precursors derived from a chromosomal deletion. Mol. Cell. Biol., 8, 1525-1533.
7. Mitelman, F., Johansson, B. and Mertens, F. (2013) Mitelman Database of Chromosome Aberrations and Gene Fusions in Cancer. http://cgap.nci.nih. gov/Chromosomes/Mitelman.
8. Gisselsson, D., Höglund, M., Mertens, F., Johansson, B., Dal Cin, P., Van den Berghe, H., Earnshaw, W.C., Mitelman, F. and Mandahl, N. (1999) The structure and dynamics of ring chromosomes in human neoplastic and non-neoplastic cells. Hum. Genet., 104, 315-325.
9. Pedeutour, F., Forus, A., Coindre, J.M., Berner, J.M., Nicolo, G., Michiels, J.F., Terrier, P., Ranchere-Vince, D., Collin, F., Myklebost, O. et al. (1999) Structure of the supernumerary ring and giant rod chromosomes in adipose tissue tumors. Genes Chromosomes Cancer, 24, 30-41.
10. Mertens, F., Panagopoulos, I., Jonson, T., Gisselsson, D., Isaksson, M., Domanski, H.A. and Mandahl, N. (2004) Retained heterodisomy for chromosome 12 in atypical lipomatous tumors: implications for ring chromosome formation. Cytogenet. Genome Res., 106, 33-38.
11. Gisselsson, D., Pettersson, L., Höglund, M., Heidenblad, M., Gorunova, L., Wiegant, J., Mertens, F., Dal Cin, P., Mitelman, F. and Mandahl, N. (2000) Chromosomal breakage-fusion-bridge events cause genetic intratumor heterogeneity. Proc. Natl. Acad. Sci. U S A, 97, 5357-5362.
12. Heidenblad, M., Hallor, K.H., Staaf, J., Jönsson, G., Borg,å ., Höglund, M., Mertens, F. and Mandahl, N. (2006) Genomic profiling of bone and soft tissue tumors with supernumerary ring chromosomes using tiling resolution bacterial artificial chromosome microarrays. Oncogene, 25, 7106-7116.
13. Wang, X., Asmann, Y.W., Erickson-Johnson, M.R., Oliveira, J.L., Zhang, H., Moura, R.D., Lazar, A.J., Lev, D., Bill, K., Lloyd, R.V. et al. (2011) High-resolution genomic mapping reveals consistent amplification of the fibroblast growth factor receptor substrate 2 gene in well-differentiated and dedifferentiated liposarcoma. Genes Chromosomes Cancer, 50, 849-858.
14. Taylor, B.S., DeCarolis, P.L., Angeles, C.V., Brenet, F., Schultz, N., Antonescu, C.R., Scandura, J.M., Sander, C., Viale, A.J., Socci, N.D. et al. (2011) Frequent alterations and epigenetic silencing of differentiation pathway genes in structurally rearranged liposarcomas. Cancer Discov., 1, 587-597.
15. Louis-Brennetot, C., Coindre, J.M., Ferreira, C., Pérot, G., Terrier, P. and Aurias, A. (2011) The CDKN2A/CDKN2B/CDK4/CCND1 pathway is pivotal in well-differentiated and dedifferentiated liposarcoma oncogenesis: an analysis of 104 tumors. Genes Chromosomes Cancer, 50, 896-907.
16. Simon, M.P., Pedeutour, F., Sirvent, N., Grosgeorge, J., Minoletti, F., Coindre, J.M., Terrier-Lacombe, M.J., Mandahl, N., Craver, R.D., Blin, N. et al. (1997) Deregulation of the platelet-derived growth factor B-chain gene via fusion with collagen gene COL1A1 in dermatofibrosarcoma protuberans and giant-cell fibroblastoma. Nat. Genet., 15, 95-98.
17. Hallor, K.H., Sciot, R., Staaf, J., Heidenblad, M., Rydholm, A., Bauer, H.C.F.,å strom, K., Domanski, H.A., Meis, J.M., Kindblom, L.G. et al. (2009) Two genetic pathways, t(1;10) and amplification of 3p11-12, in myxoinflammatory fibroblastic sarcoma, haemosiderotic fibrolipomatous tumour, and morphologically similar lesions. J. Pathol., 217, 716-727.
18. Hélias-Rodzewicz, Z., Pérot, G., Chibon, F., Ferreira, C., Lagarde, P., Terrier, P., Coindre, J.M. and Aurias, A. (2010) YAP1 and VGLL3, encoding two cofactors of TEAD transcription factors, are amplified and overexpressed in a subset of soft tissue sarcomas. Genes Chromosomes Cancer, 49, 1161-1171.
19. Santarius, T., Shipley, J., Brewer, D., Stratton, M.R. and Cooper, C.S. (2010) A census of amplified and overexpressed human cancer genes. Nat. Rev. Cancer, 10, 59-64.
20. Vogelstein, B., Papadopoulos, N., Velculescu, V.E., Zhou, S., Diaz, L.A. Jr. and Kinzler, K.W. (2013) Cancer genome landscapes. Science, 339, 1546-1558.
21. Ichimura, K., Schmidt, E.E., Goike, H.M. and Collins, V.P. (1996) Human glioblastomas with no alterations of the CDKN2A (p16INK4A, MTS1) and CDK4genes have frequent mutations of the retinoblastoma gene. Oncogene, 13, 1065-1072.
22. Eymin, B., Gazzeri, S., Brambilla, C. and Brambilla, E. (2002) Mdm2 overexpression and p14ARF inactivation are two mutually exclusive events in primary human lung tumors. Oncogene, 21, 2750-2761.
23. Gonzalez-Vasconcellos, I., Anastasov, N., Sanli-Bonazzi, B., Klymenko, O., Atkinson, M.J. and Rosemann, M. (2013) Rb1 haploinsufficiency promotes telomere attrition and radiation-induced genomic instability. Cancer Res., 73, 4247-4255.
24. McDermott, K.M., Zhang, J., Holst, C.R., Kozakiewicz, B.K., Singla, V. and Tlsty, T.D. (2006) P16(INK4a) prevents centrosome dysfunction and genomic instability in primary cells. PLoS Biol., 4, e51.
25. Rui, L., Emre, N.C., Kruhlak, M.J., Chung, H.J., Steidl, C., Slack, G., Wright, G.W., Lenz, G., Ngo, V.N., Shaffer, A.L. et al. (2010) Cooperative epigenetic modulation by cancer amplicon genes. Cancer Cell, 18, 590-605.
26. Barretina, J., Taylor, B.S., Banerji, S., Ramos, A.H., Lagos-Quintana, M., Decarolis, P.L., Shah, K., Socci, N.D., Weir, B.A., Ho, A. et al. (2010) Subtype-specific genomic alterations define new targets for soft-tissue sarcoma therapy. Nat. Genet., 42, 715-721.
27. Dei Tos, A.P. and Pedeutour, F. (2013) Atypical lipomatous tumour. In Fletcher, C.D.M., Bridge, J.A., Hogendoorn, P.C.W. and Mertens, F. (eds.), In WHO Classification of Tumours of Soft Tissue and Bone. IARC, Lyon, pp. 33-36.
28. Zhang, K., Chu, K., Wu,X., Gao, H., Wang, J., Yuan, Y.C., Loera, S., Ho, K., Wang, Y., Chow, W. et al. (2013) Amplification of FRS2 and activation of FGFR/FRS2 signaling pathway in high-grade liposarcoma. Cancer Res., 73, 1298-1307.
29. Mariani, O., Brennetot, C., Coindre, J.M., Gruel, N., Ganem, C., Delattre, O., Stern, M.H. and Aurias, A. (2007) JUN oncogene amplification and overexpression block adipocytic differentiation in highly aggressive sarcomas. Cancer Cell, 11, 361-374.
30. Snyder, E.L., Sandstrom, D.J., Law, K., Fiore, C., Sicinska, E., Brito, J., Bailey, D., Fletcher, J.A., Loda, M., Rodig, S.J. et al. (2009) c-Jun amplification and overexpression are oncogenic in liposarcoma but not always sufficient to inhibit the adipocytic differentiation programme. J. Pathol., 218, 292-300.
31. Mejia-Guerrero, S., Quejada, M., Gokgoz, N., Gill, M., Parkes, R.K., Wunder, J.S. and Andrulis, I.L. (2010) Characterization of the 12q15MDM2 and 12q13-14 CDK4 amplicons and clinical correlations in osteosarcoma. Genes Chromosomes Cancer, 49, 518-525.
32. Duhamel, L.A., Ye, H., Halai, D., Idowu, B.D., Presneau, N., Tirabosco, R. and Flanagan, A.M. (2012) Frequency of mouse double minute 2 (MDM2) and mouse double minute 4 (MDM4) amplification in parosteal and conventional osteosarcoma subtypes. Histopathology, 60, 357-359.
33. Italiano, A., Bianchini, L., Keslair, F., Bonnafous, S., Cardot-Leccia, N., Coindre, J.M., Dumollard, J.M., Hofman, P., Leroux, A., Mainguene, C. et al. (2008) HMGA2 Is the partner of MDM2 in well-differentiated and dedifferentiated liposarcomas whereas CDK4 belongs to a distinct inconsistent amplicon. Int. J. Cancer, 122, 2233-2241.
34. Italiano, A., Bianchini, L., Gjernes, E., Keslair, F., Ranchere-Vince, D., Dumollard, J.M., Haudebourg, J., Leroux, A., Mainguené, C., Terrier, P. et al. (2009) Clinical and biological significance of CDK4 amplification in well-differentiated and dedifferentiated liposarcomas. Clin. Cancer Res., 15, 5696-5703.
35. Chibon, F., Mariani, O., Derré, J., Malinge, S., Coindre, J.M., Guillou, L., Lagacé, R. and Aurias, A. (2002) A subgroup of malignant fibrous histiocytomas is associated with genetic changes similar to those of well-differentiated liposarcomas. Cancer Genet. Cytogenet., 139, 24-29.
36. Fletcher, C.D.M., Unni, K.K. and Mertens, F. (2002) World health organization classification of tumours. Pathology and genetics of tumours of soft tissue and bone. IARC Press, Lyon.
37. Shaffer, L.G., Slovak, M.L. and Campbell, L.J. (2009) ISCN (2009): An International System for Human Cytogenetic Nomenclature. S. Karger, Basel.
38. Staaf, J., Jönsson, G., Ringnér, M. and Vallon-Christersson, J. (2007) Normalization of array-CGH data: influence of copy number imbalances. BMC Genomics, 8, 382.
39. Staaf, J., Lindgren, D., Vallon-Christersson, J., Isaksson, A., Göransson, H., Juliusson, G., Rosenquist, R.,Höglund, M., Borg,Å. and Ringnér,M. (2008) Segmentation-based detection of allelic imbalance and loss-of-heterozygosity in cancer cells using whole genome SNP arrays. Genome Biol., 9, R136.
40. Sanchez-Garcia, F., Akavia, U.D., Mozes, E. and Pe'er, D. (2010) JISTIC: identification of significant targets in cancer. BMC Bioinformatics, 11, 189.
41. Iafrate, A.J., Feuk, L., Rivera, M.N., Listewnik, M.L., Donahoe, P.K., Qi, Y., Scherer, S.W. and Lee, C. (2004) Detection of large-scale variation in the human genome. Nat. Genet., 36, 949-951.
42. Jin, Y., Möller, E., Nord, K.H., Mandahl, N., Vult Von Steyern, F., Domanski, H.A., Marino-Enriquez, A., Magnusson, L., Nilsson, J., Sciot, R. et al. (2012) Fusion of the AHRR and NCOA2 genes through a recurrent translocation t(5;8)(p15;q13) in soft tissue angiofibroma results in upregulation of aryl hydrocarbon receptor target genes. Genes Chromosomes Cancer, 51, 510-520.